GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Strides Pharma Science Ltd (NSE:STAR) » Definitions » Shiller PE Ratio

Strides Pharma Science (NSE:STAR) Shiller PE Ratio : 22.19 (As of Jun. 07, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Strides Pharma Science Shiller PE Ratio?

As of today (2024-06-07), Strides Pharma Science's current share price is ₹879.65. Strides Pharma Science's E10 for the quarter that ended in Mar. 2024 was ₹39.64. Strides Pharma Science's Shiller PE Ratio for today is 22.19.

The historical rank and industry rank for Strides Pharma Science's Shiller PE Ratio or its related term are showing as below:

NSE:STAR' s Shiller PE Ratio Range Over the Past 10 Years
Min: 4.13   Med: 5.87   Max: 22.37
Current: 21.71

During the past years, Strides Pharma Science's highest Shiller PE Ratio was 22.37. The lowest was 4.13. And the median was 5.87.

NSE:STAR's Shiller PE Ratio is ranked better than
54.31% of 534 companies
in the Drug Manufacturers industry
Industry Median: 23.85 vs NSE:STAR: 21.71

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Strides Pharma Science's adjusted earnings per share data for the three months ended in Mar. 2024 was ₹2.030. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₹39.64 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Strides Pharma Science Shiller PE Ratio Historical Data

The historical data trend for Strides Pharma Science's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Strides Pharma Science Shiller PE Ratio Chart

Strides Pharma Science Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 5.11 4.60 19.79

Strides Pharma Science Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.60 7.55 9.87 13.76 19.79

Competitive Comparison of Strides Pharma Science's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Strides Pharma Science's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Strides Pharma Science's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Strides Pharma Science's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Strides Pharma Science's Shiller PE Ratio falls into.



Strides Pharma Science Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Strides Pharma Science's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=879.65/39.64
=22.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Strides Pharma Science's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Strides Pharma Science's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.03/153.0345*153.0345
=2.030

Current CPI (Mar. 2024) = 153.0345.

Strides Pharma Science Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201212 114.390 83.774 208.962
201409 -7.140 96.780 -11.290
201412 3.190 96.780 5.044
201503 1.840 97.163 2.898
201506 1.320 99.841 2.023
201509 4.430 101.753 6.663
201512 5.510 102.901 8.194
201603 20.930 102.518 31.243
201606 2.910 105.961 4.203
201609 7.770 105.961 11.222
201612 5.010 105.196 7.288
201703 12.540 105.196 18.243
201706 0.060 107.109 0.086
201709 0.960 109.021 1.348
201712 9.540 109.404 13.345
201803 63.430 109.786 88.417
201806 -0.480 111.317 -0.660
201809 -1.340 115.142 -1.781
201812 32.760 115.142 43.541
201903 5.300 118.202 6.862
201906 0.410 120.880 0.519
201909 15.940 123.175 19.804
201912 10.480 126.235 12.705
202003 -22.770 124.705 -27.943
202006 11.560 127.000 13.930
202009 9.030 130.118 10.620
202012 4.220 130.889 4.934
202103 5.130 131.771 5.958
202106 -22.880 134.084 -26.114
202109 -18.120 135.847 -20.413
202112 -13.550 138.161 -15.009
202203 3.260 138.822 3.594
202206 -15.130 142.347 -16.266
202209 2.540 144.661 2.687
202212 -8.860 145.763 -9.302
202303 -1.040 146.865 -1.084
202306 -0.790 150.280 -0.804
202309 -14.540 151.492 -14.688
202312 5.420 152.924 5.424
202403 2.030 153.035 2.030

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Strides Pharma Science  (NSE:STAR) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Strides Pharma Science Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Strides Pharma Science's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Strides Pharma Science (NSE:STAR) Business Description

Traded in Other Exchanges
Address
Strides House, Bannerghatta Road, Bilekahalli, Bengaluru, KA, IND, 560 076
Strides Pharma Science Ltd is a specialty and generic drug manufacturer. The company focuses on developing niche and complex pharmaceutical products across therapeutic segments for regulated and emerging markets. Strides' emerging-market strategy focuses on branded generics for the treatment of chronic therapies. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Strides Pharma Science (NSE:STAR) Headlines

No Headlines